Fibroblast growth factor-21 is a novel linkage between metabolic parameters, cardiovascular risk, and nephropathy in prediabetes

Fibroblast Growth Factor 21 and 23 as Biomarkers for Early Stage Diabetic Nephropathy in Type 2 Diabetic Patients

Fibroblast Growth Factor 21 as a possible metabolic marker of diabetic nephropathy in Type 2 diabetic patients

STUDY OF SERUM FIBROBLAST GROWTH FACTOR 23 IN RELATION TO DIASTOLIC DYSFUNCTION IN CHRONIC KIDNEY DISEASE PATIENTS

Serum allograft inflammatory factor-1 concentration in type 2 diabetes mellitus and its relation to the pathogenesis and progression of diabetic nephropathy

Association between Growth Differentiation Factor 15 and Cardiovascular Risk in Patients with Type 2 Diabetes Mellitus

Study of Lipoprotein-Associated Phospholipase A2 as a Potential Biomarker for Diabetic Kidney Disease in Type 2 Diabetes

Study The Association between Serum Osteoprotegerin and Diabetic Kidney Disease

Study of the association of serum level of nesfatin-1 and diabetic kidney disease in patients with type 2 diabetes

Relation of Serum Soluble Suppression of Tumorigenicity 2 with Cardiovascular Complications in Chronic Kidney Disease Patients